Talk to an expert 0800 088 235 可提供中文服务
Forgot Password

Cell Care Pricing.jpegWhy Choose Cell Care?

By choosing Cell Care, you are storing with one of the world’s leading cord blood banks with operations in Australia and North America, and now offering its service to New Zealand’s expectant parents.

With Cell Care in New Zealand, you now have access to:

  • A much more affordable and accessible service – reflecting international price levels
  • Both cord blood and cord tissue storage options: cord tissue has different types of cells with anti-inflammatory and immunomodulatory properties
  • More investment in umbilical cord stem cell research and clinical trials. Cell Care sponsors world leading trials and invests in cord blood expansion technology, and finances research in the use of cord tissue-derived cells
  • No cost for the release and transport of your cord blood for approved therapeutic uses
  • A full refund if your cord blood or tissue is not collected or stored

 

Cell Care is licensed by Medsafe and the Therapeutic Goods Administration Australia and is a leading cord blood and tissue bank in:

  • Experience
  • Releases
  • Research and Scientific Capability
  • Education
  • Customer Service
  • Innovation

Experience Experience.jpg

Cell Care has collected and stored cord blood and tissue stem cells for over 200,000 families. We look forward to providing New Zealand expectant parents with a more affordable and innovative cord blood banking service.

Cell Care's experience

 

The Cell Care Group

 Cord Bank

Total newborn collections stored

200,000

Approx. 12,000

Deposit at enrolment

$99

$145

Upfront price: cord blood on annual plan $1,900 $2,100
Cord Blood annual storage fee $175 $225
Flexible Prepaid payment plans offered -
Courier costs Included Variable
Full refund if collection does not proceed -
Clinical trial sponsorship -
Number of releases 80+ 8
Accredited with Medsafe

Releases Release of Samples.jpg

Cord blood stored with Cell Care has been used (released) in place of bone marrow to regenerate the blood and immune systems after being damaged by diseases like Thalassaemia. We have also released cord blood in the setting of clinical trials.

Cell Care is focused on increasing the potential use of stem cells by partnering with leading research institutions to establish approved clinical trials in regenerative medicine. These groundbreaking trials only use cord blood stem cells processed by Cell Care as a way of ensuring consistent quality.

Importantly, there are no charges incurred to release your cord blood for regulator-approved use(s) and Cell Care will deliver it using dedicated medical transportation to any hospital in the world; free of charge.

Research and scientific capabilityResearch.jpg

Cell Care has a steadfast commitment to the ongoing development of stem cell therapy science and research. We take pride in the fact that we are the only cord blood and tissue bank in Australia and New Zealand participating in cell therapy clinical trials. 

 

EducationEducation.jpg

Cell Care, the leader in cord blood banking in both Australia and Canada, educates thousands of expectant parents in the current uses and future potential of umbilical cord stem cells. With more information, expectant parents make better informed decisions.

Customer ServiceCustomer Service.jpg

Cell Care's highly experienced client services team guides parents through every stage of the cord blood and tissue storage process. We provide in-depth information and ongoing updates as to how the science of stem cell treatments and research is evolving.

InnovationInnovation.jpg

Cell Care is the leader in cord blood and tissue innovation. We are the only company investing in cord blood clinical trials. Cell Care is the first to offer Australian and New Zealand families the option to store cord tissue which will potentially expand future therapy options.

Government licensed

Cell Care operates in New Zealand with a Medsafe approved manufacturing licence. In Australia, Cell Care is licenced by the Therapeutic Goods Administration (TGA).

In Canada, Cell Care’s subsidiary Insception Biosciences Inc. operates with certifications provided by AABB, Netcord-FACT and Health Canada.

Cell Care’s Medsafe license

License number – 137/21/1

Cell Care's TGA license

License number - MI-2009-LI-04618-3

Insception’s Health Canada certification details

Certificate number – 100042

Cord blood storage & processing

Cord blood processing

Pregnancy and birth can be an unpredictable process and this may impact the volume of cord blood collected at the time of birth. Cell Care does not use a minimum collection volume to determine if your cord blood sample will be stored. Rather, the number of stem cells and their viability will dictate the storage potential.

Cell Care use state of the art equipment including flow cytometers and cell impedance counters to assess the cord blood samples. Our processes enable us to determine the quality of your cord blood sample upon storage. In the event your cord blood sample does not meet certain important measures you will be notified immediately to discuss your options.

Cell Care’s cord blood measures

Measure

Description

Total Cell Count

The number of total nucleated cells in your cord blood sample

Viability

The percentage of cells which are able to replicate and grow

Stem Cell Count

The number of stem cells in your cord blood sample

Cell Care’s storage facility

Cell Care provides a safe and secure environment for your baby’s cord blood and tissue stem cells with access restricted to authorised personnel. Cell Care’s laboratories, environment and samples are monitored 24/7 for storage temperature, fire and security. Early warning systems are in place to identify any potential problem long before cells could be impacted.

Laboratories and equipment

Cell Care is a member of the Victoria Consortium for Cellular Therapies (VCCT). Cell Care houses multiple advanced optipress machines, cell impedance counters and flow cytometry equipment to meet all regulatory and scientific requirements for cell storage. We have invested in technology to maximise the likelihood of storing cord blood even in the event of lower volumes.

Quality management systems  

Cell Care operates according to the highest level of quality management systems. All of Cell Care’s processes are structured in accordance with the Australian code of Good Manufacturing Practice (cGMP) and the Foundation of Accredited Cellular Therapies standard (FACT/ Netcord). Cell Cares’ processes aim to ensure full product compliance, traceability and quality control of your baby’s cord blood and tissue.

Financial security

Cell Care is a 100% privately owned Australian company. All cord blood and tissue products are stored on site in our state of the art facility. The company is experiencing exponential growth as cord blood and tissue storage becomes commonplace in both Australia and New Zealand. Our key investors have a strong commitment to the Australian and New Zealand health care and medical research sectors.